UBS lowered Oracle's price target from $285 to $245 due to concerns over rising AI infrastructure costs, credit market tightness, and Oracle's exposure to OpenAI. Despite these risks, UBS maintained a Buy rating, noting that some worries, like delays in Oracle's New Mexico data center project, may be overstated. The analysts see potential upside in Oracle's fiscal 2027 guidance and believe the stock's valuation already reflects material risks. Future gains depend on clearer returns from AI investments and Oracle's ability to expand its AI offerings amid competition.
Oracle Corporation reported solid Q1 results with revenue of $19.35 billion and earnings per share 10% above expectations. Cloud infrastructure led growth with a 121% increase, pushing total cloud revenue up 62% year-over-year to represent 60% of tot...
Oracle Corporation reported strong Q1 FY2027 results, surpassing revenue, EPS, and margin expectations driven by 121% year-over-year growth in Oracle Cloud Infrastructure (OCI). Despite significant capital expenditures and a $20 billion equity raise ...
Oracle reported first-quarter revenue of $19.3 billion, surpassing analyst estimates of $19.14 billion, driven by a surge in AI cloud infrastructure demand. Adjusted earnings per share were $1.92, beating the $1.74 estimate, while cloud revenue reach...
Oracle reported fiscal Q1 results surpassing expectations with revenue of $19.35 billion, up nearly 30% year-over-year, and adjusted earnings per share of $1.92 versus $1.74 expected. The company’s cloud revenue soared 62%, driven by strong demand fo...
Oracle reported a 30% increase in Q1 total revenues to $19.3 billion, driven by a 62% surge in cloud revenues, including 121% growth in cloud infrastructure. GAAP earnings per share rose 55% to $1.56, reflecting strong demand and expanded data center...
